Biolase Inc: Top pct gainer on Q1 revenue beat, strong forecast

November 26

14/05/2021 12:13

** Medical device maker's shares  BIOL.O  up nearly 33% at
$0.77 premarket, top pct gainer across U.S. exchanges
    ** BIOL said on Thursday Q1 revenue rose about 70% to $8.1
mln vs est $7.8 mln - Refinitiv Eikon  urn:newsml:reuters.com:*:nPn2PKrjWa
    ** Quarterly results helped by robust demand for dental
lasers due to recovery in patient volumes
    ** Company expects Q2 revenue between $7.5 mln and $8.5 mln,
growth of 155%-190% y-o-y
    ** BIOL shares up 39.2% YTD as of last close

 (Reporting by Amruta Khandekar)
 ((Amruta.Khandekar@thomsonreuters.com))